Fate of Nutrient-Derived Amino Acids, FONDAA
FONDAA
1 other identifier
interventional
12
1 country
1
Brief Summary
12 elderly (65-70 years of age) male subjects will be included and complete a double blinded cross-over study. They will be habituated for 21 days to either low or high protein intake (below 0.8 g/kg or above 1.5 g/kg, respectively). Following a 45 day washout period they will switch to the alternate group. At the end of each habituation period, the investigators will measure the appearance of labelled amino acids from milk proteins.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 22, 2015
CompletedFirst Posted
Study publicly available on registry
October 27, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2018
CompletedMarch 5, 2018
March 1, 2018
2.4 years
October 22, 2015
March 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abundance of milk protein-bound amino acid labels in blood protein.
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in liver-synthesized blood protein at 240 min.
Baseline to 240 min postprandial
Secondary Outcomes (10)
Abundance of milk protein-bound amino acid labels in myofibrillar protein.
Baseline to 240 min postprandial
Leg phenylalanine rate of disappearance and appearance, net balance.
Baseline to 240 min postprandial
First pass splanchnic extraction of dietary protein-derived labeled phenylalanine.
Baseline to 240 min postprandial
Whole body phenylalanine rate of disappearance and appearance, net balance.
Baseline to 240 min postprandial
The myofibrillar protein fractional synthesis rate
Baseline to 240 min postprandial
- +5 more secondary outcomes
Study Arms (2)
Meal serving at high dietary protein
EXPERIMENTALTest the handling of meal-served protein when habituated to high dietary protein at an amount above 1.5 g protein/kg/day
Meal serving at low dietary protein
ACTIVE COMPARATORTest the handling of meal-served protein when habituated to high dietary protein at an amount below 0.8 g protein/kg/day
Interventions
Participants are habituated to a high level of dietary protein intake for 21 days.
Participants are habituated to a low level of dietary protein intake for 21 days.
To investigate impact of habituated protein level
Eligibility Criteria
You may not qualify if:
- Hyperlipidemia
- Hypertension
- Males age 65-70
- Independently dwelling
- Without any major health issues (blood pressure, cholesterol and lipid profile will be measured and evaluated by a physician)
- Non-diabetic
- No organ disease
- No back pain
- Not regularly take any prescription drugs or dietary supplements, which can influence muscle protein synthesis
- Alcohol intake below 21 units pr. week
- No known arthrosclerosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Medicine Copenhagen
Copenhagen, 2400, Denmark
Related Publications (1)
Hojfeldt G, Bulow J, Agergaard J, Asmar A, Schjerling P, Simonsen L, Bulow J, van Hall G, Holm L. Impact of habituated dietary protein intake on fasting and postprandial whole-body protein turnover and splanchnic amino acid metabolism in elderly men: a randomized, controlled, crossover trial. Am J Clin Nutr. 2020 Dec 10;112(6):1468-1484. doi: 10.1093/ajcn/nqaa201.
PMID: 32710741DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Grith Højfeldt, M.Sc.
Bispebjerg Hospital
- PRINCIPAL INVESTIGATOR
Lars Holm, Ph.D.
Bispebjerg Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc. Human Biology - PhD student
Study Record Dates
First Submitted
October 22, 2015
First Posted
October 27, 2015
Study Start
October 1, 2015
Primary Completion
February 8, 2018
Study Completion
February 8, 2018
Last Updated
March 5, 2018
Record last verified: 2018-03